Clinical Trial Update: Study Comparing Full-dose Radiotherapy Versus Reduced Dose in the Management of Bone Metastasis in Patients With Breast Cancer Receiving Zoledronic Acid [Phase 4]

View source ↗

Summary

Phase 4 trial comparing full-dose radiotherapy to reduced-dose radiotherapy for bone metastases in breast cancer patients receiving zoledronic acid has complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer with Metastatic Bone Disease

Drugs mentioned

• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Novartis | Conditions: Breast Cancer With Metastatic Bone Disease | Phase 4 | Status: COMPLETED